kavehdaneshvar Profile Banner
Kaveh Daneshvar Profile
Kaveh Daneshvar

@kavehdaneshvar

Followers
1K
Following
3K
Media
35
Statuses
775

Gene & RNA Therapies | Building a new venture. Past: @Arbortx | @Tome_bio, @FlagshipPioneer, and @Harvard

Cambridge, MA
Joined January 2016
Don't wanna be here? Send us removal request.
@kavehdaneshvar
Kaveh Daneshvar
5 years
Our findings @NatureCellBio suggest a role for lncRNA-protein condensates in transcriptional regulation. We show that a lncRNA promotes the nucleation of bromodomain protein condensates on active chromatin and control their transcriptional activity. https://t.co/qEISd28V8n
17
48
192
@Langsammer03
Alexandro Landshammer, PhD
3 years
🚨!!!Preprint Alert!!!🚨 I am super-delighted to share our work co-led with @adrianobolondi describing the discovery and characterization of a novel lncRNA, LNCSOX17, a key regulator of human definitive endoderm. #Meissner Lab @MPI_MolGen. A🧵1/11
Tweet card summary image
biorxiv.org
Long non-coding RNAs (lncRNAs) have emerged as fundamental regulators in various biological processes, including embryonic development and cellular differentiation. Despite much progress over the...
5
15
60
@jgooten
Jonathan Gootenberg
4 years
New preprint! How do you insert large genes efficiently + programmatically? CRISPR-based methods are programmable, integrases are efficient. Why not combine them? PASTE places short (~45bp) integrase landing sites that serve as beacons for insertion (up to 36kb)! @omarabudayyeh
@biorxivpreprint
bioRxiv
4 years
Drag-and-drop genome insertion without DNA cleavage with CRISPR-directed integrases https://t.co/sYO6wWyTLO #bioRxiv
5
75
365
@kavehdaneshvar
Kaveh Daneshvar
4 years
Any suggestions for a high-yield T7 IVT kit that makes 5'-capped, 3'-poylA tailed mRNA with modified nucleotides (e.g. 5mCTP, ψUTP) to avoid cell immune response?
1
0
2
@kavehdaneshvar
Kaveh Daneshvar
4 years
I wonder what type of biases and discriminations this algorithm is going to reinforce. Also, reminds me of this good book on a related topic:
goodreads.com
We live in the age of the algorithm. Increasingly, the …
@NaturePortfolio
Nature Portfolio
4 years
A machine-learning model can be used to predict the future “impact” of research published in scientific literature, according to a @NatureBiotech paper. The model could aid in the construction of diversified, impact-optimized funding portfolios. https://t.co/SX592OYIsj
0
2
3
@LeeZou8
Lee Zou
5 years
Glad to share our latest paper on a new role of RNA in homologous recombination. Thanks to members of my team and our collaborators! RNA transcripts stimulate homologous recombination by forming DR-loops | Nature
15
83
405
@MehrsaBaradaran
Mehrsa Baradaran
5 years
My boomer parents can't identify spam emails. My zoomer kids can't identify junk mail. Gen X FTW!
7
12
218
@SztubaSolinska
Joanna Sztuba-Solińska
5 years
Our pre-print is alive! We showed that KSHV-encoded polyadenylated nuclear (PAN) lncRNA is m6A modified by using 2nd and 3rd gen seq, identified frequency of m6A by a new method - SLAP, its structural impact, and related methylome
3
13
60
@kavehdaneshvar
Kaveh Daneshvar
5 years
Come work with us in a highly collaborative biotech venture ecosystem! I am hiring a Ph.D. scientist with expertise in molecular biology & protein biochemistry. We're developing new therapeutic modalities targeting RNA.
Tweet card summary image
flagshippioneering.com
Flagship is a brave, bold organization and our people are creative thinkers, exceptional scientists and experienced company builders. Together we are on a…
0
11
13
@kavehdaneshvar
Kaveh Daneshvar
5 years
Hopping transposable elements generating diversity in transcription factors! Very interesting paper and thread.
@CedricFeschotte
Cedric🧬➰🧬Feschotte
5 years
💥It's published! 🎉 Recurrent evolution of vertebrate transcription factors by transposase capture 6+ years in the making! The story in a nutshell 🧵1/n https://t.co/lukYqgq1eS
0
0
6
@amymaxmen
Amy Maxmen, PhD
5 years
"The world is on the brink of a catastrophic moral failure," says @DrTedros @WHO. >39 Million vaccine doses have been administered in 49 high-income countries. 25 (just 25) doses have been given in one low-income country.
27
416
779
@kavehdaneshvar
Kaveh Daneshvar
5 years
Three days to register for my graduate course on RNA Therapeutics. Open to scientists, innovators, and students who want to learn about the progress in RNA-focused drug development. Syllabus: https://t.co/wsyTln0e8B Registration:
0
4
9
@kavehdaneshvar
Kaveh Daneshvar
5 years
Has anyone called outliers “socially distant datapoint” yet?
1
1
8
@kavehdaneshvar
Kaveh Daneshvar
5 years
Does a single nucleotide change in the sequence of approved mRNA vaccines trigger a new clinical trial?
2
0
4
@kavehdaneshvar
Kaveh Daneshvar
5 years
“Valonia ventricosa” (bubble algae), possibly the largest unicellular organism.
0
0
18
@kavehdaneshvar
Kaveh Daneshvar
5 years
These flight attendants having a little Christmas dinner together up in the sky was the greatest thing I saw today. @Delta
0
0
3
@Zhaleh_julie
Zhaleh Safikhani
5 years
For those of you who are amazed by the invention of the novel RNA vaccines for COVID-19 and are eager to learn (more) about RNA Therapeutics @kavehdaneshvar is presenting an amazing course at Harvard on RNA-based Drugs and RNA Therapeutics.
2
1
11
@kavehdaneshvar
Kaveh Daneshvar
5 years
Best way to record a presentation/talk? need a backup up for a live session, in case things fail.
1
0
2
@kavehdaneshvar
Kaveh Daneshvar
5 years
Sharing your successes with friends can build trust. I wonder if sharing "only successes" and not "failures" could ruin the trust, or build anxiety in others.
@AdamMGrant
Adam Grant
5 years
We sometimes hide our successes to protect our friends and colleagues, but it actually hurts our relationships. New research: concealing achievements is an insult. When we share our successes, people are more likely to trust us and celebrate with us— and less likely to envy us.
0
0
12